Article Versions Notes

Vlachopoulou D, Balomenakis C, Kartas A, Samaras A, Papazoglou AS, Moysidis DV, Barmpagiannos K, Kyriakou M, Papanastasiou A, Baroutidou A, et al. Cardioselective versus Non-Cardioselective Beta-Blockers and Outcomes in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine. 2023; 12(9):3063. https://doi.org/10.3390/jcm12093063

Vlachopoulou, Dimitra, Charalampos Balomenakis, Anastasios Kartas, Athanasios Samaras, Andreas S. Papazoglou, Dimitrios V. Moysidis, Konstantinos Barmpagiannos, Melina Kyriakou, Anastasios Papanastasiou, Amalia Baroutidou, and et al. 2023. "Cardioselective versus Non-Cardioselective Beta-Blockers and Outcomes in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease" Journal of Clinical Medicine 12, no. 9: 3063. https://doi.org/10.3390/jcm12093063

Vlachopoulou, D., Balomenakis, C., Kartas, A., Samaras, A., Papazoglou, A. S., Moysidis, D. V., Barmpagiannos, K., Kyriakou, M., Papanastasiou, A., Baroutidou, A., Vouloagkas, I., Tzikas, A., & Giannakoulas, G. (2023). Cardioselective versus Non-Cardioselective Beta-Blockers and Outcomes in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine, 12(9), 3063. https://doi.org/10.3390/jcm12093063